177 related articles for article (PubMed ID: 23403125)
1. Identification of the general transcription factor Yin Yang 1 as a novel and specific binding partner for S6 kinase 2.
Ismail HM; Myronova O; Tsuchiya Y; Niewiarowski A; Tsaneva I; Gout I
Cell Signal; 2013 May; 25(5):1054-63. PubMed ID: 23403125
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.
Park IH; Bachmann R; Shirazi H; Chen J
J Biol Chem; 2002 Aug; 277(35):31423-9. PubMed ID: 12087098
[TBL] [Abstract][Full Text] [Related]
3. Characterization of S6K2, a novel kinase homologous to S6K1.
Lee-Fruman KK; Kuo CJ; Lippincott J; Terada N; Blenis J
Oncogene; 1999 Sep; 18(36):5108-14. PubMed ID: 10490847
[TBL] [Abstract][Full Text] [Related]
4. Development of monoclonal antibodies specific to ribosomal protein S6 kinase 2.
Savinska L; Skorokhod O; Klipa O; Gout I; Filonenko V
Hybridoma (Larchmt); 2012 Aug; 31(4):289-94. PubMed ID: 22894784
[TBL] [Abstract][Full Text] [Related]
5. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.
Magnuson B; Ekim B; Fingar DC
Biochem J; 2012 Jan; 441(1):1-21. PubMed ID: 22168436
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1.
Phin S; Kupferwasser D; Lam J; Lee-Fruman KK
Biochem J; 2003 Jul; 373(Pt 2):583-91. PubMed ID: 12713446
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal S6 kinase 2 inhibition by a potent C-terminal repressor domain is relieved by mitogen-activated protein-extracellular signal-regulated kinase kinase-regulated phosphorylation.
Martin KA; Schalm SS; Romanelli A; Keon KL; Blenis J
J Biol Chem; 2001 Mar; 276(11):7892-8. PubMed ID: 11108720
[TBL] [Abstract][Full Text] [Related]
8. SKAR is a specific target of S6 kinase 1 in cell growth control.
Richardson CJ; Bröenstrup M; Fingar DC; Jülich K; Ballif BA; Gygi S; Blenis J
Curr Biol; 2004 Sep; 14(17):1540-9. PubMed ID: 15341740
[TBL] [Abstract][Full Text] [Related]
9. Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway.
Goh ET; Pardo OE; Michael N; Niewiarowski A; Totty N; Volkova D; Tsaneva IR; Seckl MJ; Gout I
J Biol Chem; 2010 May; 285(22):17065-76. PubMed ID: 20308064
[TBL] [Abstract][Full Text] [Related]
10. S6 kinase 2 is bound to chromatin-nuclear matrix cellular fractions and is able to phosphorylate histone H3 at threonine 45 in vitro and in vivo.
Ismail HM; Hurd PJ; Khalil MI; Kouzarides T; Bannister A; Gout I
J Cell Biochem; 2014 Jun; 115(6):1048-62. PubMed ID: 23564320
[TBL] [Abstract][Full Text] [Related]
11. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.
Pende M; Um SH; Mieulet V; Sticker M; Goss VL; Mestan J; Mueller M; Fumagalli S; Kozma SC; Thomas G
Mol Cell Biol; 2004 Apr; 24(8):3112-24. PubMed ID: 15060135
[TBL] [Abstract][Full Text] [Related]
12. The polyproline-motif of S6K2: eIF5A translational dependence and importance for protein-protein interactions.
Meneguello L; Barbosa NM; Pereira KD; Proença ARG; Tamborlin L; Simabuco FM; Iwai LK; Zanelli CF; Valentini SR; Luchessi AD
J Cell Biochem; 2019 Apr; 120(4):6015-6025. PubMed ID: 30320934
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitination of ribosomal S6 kinases is independent from the mitogen-induced phosphorylation/activation of the kinase.
Gwalter J; Wang ML; Gout I
Int J Biochem Cell Biol; 2009 Apr; 41(4):828-33. PubMed ID: 18786649
[TBL] [Abstract][Full Text] [Related]
14. mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice.
Antion MD; Hou L; Wong H; Hoeffer CA; Klann E
Mol Cell Biol; 2008 May; 28(9):2996-3007. PubMed ID: 18316404
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway.
Martin KA; Schalm SS; Richardson C; Romanelli A; Keon KL; Blenis J
J Biol Chem; 2001 Mar; 276(11):7884-91. PubMed ID: 11108711
[TBL] [Abstract][Full Text] [Related]
16. Identification of S6K2 as a centrosome-located kinase.
Rossi R; Pester JM; McDowell M; Soza S; Montecucco A; Lee-Fruman KK
FEBS Lett; 2007 Aug; 581(21):4058-64. PubMed ID: 17678899
[TBL] [Abstract][Full Text] [Related]
17. Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site.
Ali SM; Sabatini DM
J Biol Chem; 2005 May; 280(20):19445-8. PubMed ID: 15809305
[TBL] [Abstract][Full Text] [Related]
18. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes.
Wang L; Gout I; Proud CG
J Biol Chem; 2001 Aug; 276(35):32670-7. PubMed ID: 11431469
[TBL] [Abstract][Full Text] [Related]
20. [Features of fibronectin-dependent activation of ribosomal protein S6 kinase (S6K1 and S6K2)].
Val'ovka TI; Filonenko VV; Velykyï MM; Drobot LB; Voterfill M; Matsuka HKh; Hut IT
Ukr Biokhim Zh (1999); 2000; 72(3):31-7. PubMed ID: 11200472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
